SOFIA (Bulgaria), September 25 (SeeNews) – Bulgarian veterinary drugs producer Biovet [BUL:53B] said it will ask shareholders approval to pledge the company as collateral for loans of a total 275 million euro ($349.7 million) to be drawn by its parent Huvepharma